Apichard Sukonthasarn
Overview
Explore the profile of Apichard Sukonthasarn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chia Y, He F, Cheng M, Shin J, Cheng H, Sukonthasarn A, et al.
Hypertens Res
. 2024 Oct;
48(1):301-313.
PMID: 39472546
Cardiovascular diseases (CVD) continue to be the leading cause of deaths and disability worldwide and the major contributor is hypertension. Despite all the improvements in detecting hypertension together with technological...
2.
Chotruangnapa C, Kunanon S, Sukonthasarn A, Srinonprasert V, Beaney T, Clarke J, et al.
Eur Heart J Suppl
. 2024 Jul;
26(Suppl 3):iii90-iii92.
PMID: 39055587
Blood pressure (BP) measurement is the mainstay for diagnosing and treating hypertension. Blood pressure screening in the May Measurement Month (MMM) project is helpful for the early detection of hypertension,...
3.
Chattranukulchai P, Roubsanthisuk W, Kunanon S, Kotruchin P, Satirapoj B, Wongpraparut N, et al.
Hypertens Res
. 2024 Jul;
47(9):2447-2455.
PMID: 39014113
Resistant hypertension (RH) includes hypertensive patients with uncontrolled blood pressure (BP) while receiving ≥3 BP-lowering medications or with controlled BP while receiving ≥4 BP-lowering medications. The exact prevalence of RH...
4.
Sukonthasarn A, Borghi C, Chan Y, Cheng F, Choi H, Mehta R, et al.
Eur J Intern Med
. 2024 Jul;
127:25-30.
PMID: 38960822
Hypertension remains a major problem worldwide, especially across the Asia-Pacific region, which reports high prevalence rates and slow improvements in treatment rate and blood pressure (BP) control rate. Asian patients...
5.
Widyantoro B, Nailes J, Sukonthasarn A, Soenarta A
J Clin Hypertens (Greenwich)
. 2024 Apr;
26(12):1362-1367.
PMID: 38563647
High blood pressure (BP) remains a major health problem globally, with a proportion of hypertension-mediated organ damage (HMOD) increasing worldwide including in Asia region. Cardiovascular (CV), cerebral and kidney diseases...
6.
Angelico F, Alcantara-Payawal D, Rani R, Mustafa N, Thongtang N, Chaiteerakij R, et al.
Drugs Context
. 2024 Jan;
13.
PMID: 38264403
Metabolic-associated fatty-liver disease (MAFLD), previously known as non-alcoholic fatty liver disease, is the most widespread and emerging chronic liver disease worldwide, with increasing prevalence rates also in the Asia-Pacific region....
7.
Ray S, Nair T, Sawhney J, Erwinanto , Rosman A, Reyes E, et al.
Curr Med Res Opin
. 2023 Sep;
39(12):1671-1683.
PMID: 37694536
Objective: This Delphi method of consensus was designed to develop scientific statements for β-blockers in the continuum of cardiovascular diseases with a special focus on the role of bisoprolol. Methods:...
8.
Kario K, Tomitani N, Wang T, Park S, Li Y, Shin J, et al.
Hypertens Res
. 2023 Aug;
46(12):2561-2574.
PMID: 37605071
Recent innovations in digital technology have enabled the simultaneous accumulation, and the linking and analysis of time-series big data relating to several factors that influence blood pressure (BP), including biological...
9.
Wang T, Ohkubo T, Bunyi M, Chadachan V, Chia Y, Kario K, et al.
Hypertens Res
. 2023 Apr;
46(7):1638-1649.
PMID: 37041412
Uncontrolled hypertension is a significant problem in many parts of Asia. Effective management is essential to reduce the burden of hypertension. Home blood pressure monitoring (HBPM) is a promising tool...
10.
Roubsanthisuk W, Kunanon S, Chattranukulchai P, Panchavinnin P, Wongpraparut N, Chaipromprasit J, et al.
Hypertens Res
. 2023 Feb;
46(4):898-912.
PMID: 36759658
Hypertension remains a significant risk factor for major cardiovascular events worldwide. Poor adherence to treatment is extremely common in clinical practice, leading to uncontrolled hypertension. However, some patients with resistant...